AVERIN et al.
8.1 Hz), 7.90 d (1H, J = 4.8 Hz), 7.97 br.s (1H),
6
3
141.2 (1C), 144.9 (1C). Mass spectrum: m/z 348.235
[M + H]+. C23H30N3. Calculated: (M + H) 348.244.
3
4
8.21 d (2H, J = 4.5 Hz), 8.31 d (2H, J = 2.3 Hz).
13C NMR spectrum, δC, ppm: 28.8 (2C), 32.6 (2C),
36.3 (1C), 38.2 (1C), 40.1 (1C), 41.5 (2C), 41.8 (2C),
43.4 (1C), 46.9 (1C), 47.4 (1C), 118.3 (1C), 123.6
(1C), 123.8 (2C), 127.4 (2C), 135.8 (1C), 138.4 (1C),
142.7 (2C), 142.9 (2C), 143.2 (2C), 144.3 (1C). Mass
spectrum: m/z 454.302 [M + H]+. C29H36N5. Calculat-
ed: (M + H) 454.297.
N-(4-{3-[2-(Pyridin-3-ylamino)ethyl]adamantan-
1-yl}phenyl)pyridin-3-amine (XXVI) was synthe-
sized from 0.25 mmol (68 mg) of diamine XIX and
0.5 mmol (79 mg) of 3-bromopyridine in the presence
of 4 mol % (6 mg) of Pd(dba)2, 4.5 mol % (7 mg) of
BINAP, and 0.75 mmol (73 mg) of sodium tert-butox-
ide in 2.5 ml of dioxane. The product was isolated by
chromatography using CH2Cl2–MeOH (20:1) as
eluent. Yield 60 mg (56%). 1H NMR spectrum, δ, ppm:
1.45–1.49 m (2H), 1.51–1.71 m (8H), 1.84 br.s (4H),
2.17 br.s (2H), 3.11–3.15 m (2H), 3.62 br.s (1H),
N-({3,5-Dimethyl-7-[2-(pyridin-3-ylamino)ethyl]-
adamantan-1-yl}methyl)pyridin-3-amine (XXIV)
was synthesized from 0.25 mmol (59 mg) of diamine
XVIII and 0.55 mmol (87 mg) of 3-bromopyridine in
the presence of 4 mol % (6 mg) of Pd(dba)2, 4.5 mol %
(7 mg) of DavePhos, and 0.73 mmol (70 mg) of
sodium tert-butoxide in 2.5 ml of dioxane. The product
was isolated by chromatography using CH2Cl2–MeOH
(20:1 to 10:1) as eluent. Yield 46 mg (47%). H NMR
spectrum, δ, ppm: 0.86 s (6H), 1.12–1.22 m (12H),
1.45–1.49 m (2H), 2.86 d (2H, J = 5.8 Hz), 3.09–
3.12 m (2H), 3.54 br.s (1H), 3.72 br.s (1H), 6.82 d.d.d
3
4
6.07 br.s (1H), 6.82 d.d.d (1H, J = 8.2, J = 2.8,
3
1.4 Hz), 7.02–7.07 m (3H), 7.11 d.d (1H, J = 8.2,
4.7 Hz), 7.26 d (2H, 3J = 8.5 Hz), 7.34 d.d.d (1H, J =
3
3
8.3, 4J = 2.7, 1.5 Hz), 7.92 d (1H, J = 4.7 Hz), 7.99 d
(1H, 4J = 2.8 Hz), 8.10 d (1H, 3J = 4.7 Hz), 8.33 d (1H,
1
4J = 2.7 Hz). C NMR spectrum, δC, ppm: 29.2 (2C),
13
3
33.0 (1C), 36.0 (1C), 36.4 (1C), 38.2 (1C), 41.6 (2C),
42.5 (2C), 43.5 (1C), 48.5 (1C), 118.3 (1C), 118.5
(2C), 122.7 (1C), 123.6 (1C), 123.7 (1C), 125.8 (2C),
135.9 (1C), 138.4 (1C), 139.5 (1C), 139.6 (1C), 140.3
(1C), 141.3 (1C), 144.4 (1C), 144.6 (1C). Mass spec-
trum: m/z 425.266 [M + H]+. C28H33N4. Calculated:
(M + H) 425.271.
3
4
3
(1H, J = 8.3, J = 2.9, 1.3 Hz), 6.85 d.d.d (1H, J =
8.3, 4J = 2.9, 1.3 Hz), 7.02–7.07 m (2H), 7.90 d.d (1H,
3J = 4.6, J = 2.9 Hz), 7.93 d.d (1H, J = 4.7, J =
4
3
4
4
4
2.9 Hz), 7.98 d (1H, J = 1.3 Hz), 8.02 d (1H, J =
13
1.3 Hz). C NMR spectrum, δC, ppm: 30.1 (2C), 31.7
(2C), 34.2 (1C), 36.5 (1C), 38.4 (1C), 42.7 (1C), 44.4
(1C), 46.4 (2C), 48.3 (2C), 50.6 (1C), 54.9 (1C), 118.1
(1C), 118.3 (1C), 123.6 (2C), 135.9 (1C), 136.0 (1C),
138.3 (1C), 138.5 (1C), 144.3 (1C), 145.0 (1C). Mass
spectrum: m/z 391.288 [M + H]+. C25H35N4. Calculat-
ed: (M + H) 391.286.
This study was performed under financial support
by the Russian Academy of Sciences (program no. P-8,
“Development of the Methodology of Organic Synthe-
sis and Design of Compounds with Valuable Practical
Properties”) and by the Russian Foundation for Basic
Research (project no 10-03-01108).
N-{4-[3-(2-Aminomethyl)adamantan-1-yl]-
phenyl}pyridin-3-amine (XXV) was synthesized
from 0.37 mmol (102 mg) of diamine XIX and
0.37 mmol (60 mg) of 3-bromopyridine in the presence
of 4 mol % (9 mg) of Pd(dba)2, 4.5 mol % (10 mg) of
BINAP, and 0.56 mmol (54 mg) of sodium tert-butox-
ide in 3.5 ml of dioxane. The product was isolated by
chromatography using CH2Cl2–MeOH–aq. NH3
REFERENCES
1. Grigorova, O.K., Averin, A.D., Abel, A.S., Maloshits-
kaya, O.A., Butov, G.M., Savelyev, E.N., Orlinson, B.S.,
Novakov, I.A., and Beletskaya, I.P., Russ. J. Org.
Chem., 2012, vol. 48, p. 1495.
2. Morozov, I.S., Petrov, V.I., and Sergeeva, S.A., Farma-
kologiya adamantanov (Pharmacology of Adaman-
tanes), Volgograd: Volgograd. Med. Akad., 2001.
3. Klimova, N.V., Zaitseva, N.M., Avdyunina, N.I.,
Pyatin, B.M., Morozov, I.S., Bykov, N.P., and Kuz’-
min, V.I., Khim.-Farm. Zh., 1990, no. 1, p. 26.
4. Avdyunina, N.I., Klimova, N.V., Kuz’min, V.I., Moro-
zov, I.S., Pyatin, B.M., and Smirnov, L.D., Russian
Patent no. 1055105, 1992; Chem. Abstr., 1992,
vol. 117, no. P124497w.
1
(100:20:1) as eluent. Yield 40 mg (31%). H NMR
spectrum, δ, ppm: 1.30–1.34 m (2H), 1.45–1.69 m
(10H), 1.76–1.86 m (4H), 2.13 br.s (2H), 2.70–2.74 m
(2H), 5.95 br.s (1H), 7.03 d (2H, 3J = 8.7 Hz), 7.12 d.d
3
3
(1H, J = 8.3, 4.7 Hz), 7.26 d (2H, J = 8.7 Hz),
3
4
7.35 d.d.d (1H, J = 8.3, J = 2.8, 1.5 Hz), 8.10 d.d
3
4
4
(1H, J = 4.7, J = 1.5 Hz), 8.33 d (1H, J = 2.8 Hz).
13C NMR spectrum, δC, ppm: 29.2 (2C), 33.0 (1C),
36.1 (1C), 36.4 (1C), 36.5 (1C), 41.6 (2C), 42.6 (2C),
48.3 (1C), 48.6 (1C), 118.5 (2C), 122.6 (1C), 123.6
(1C), 125.8 (2C), 139.3 (1C), 139.5 (1C), 140.3 (1C),
5. Averin, A.D., Ulanovskaya, M.A., Kovalev, V.V., Bu-
ryak, A.K., Orlinson, B.S., Novakov, I.A., and Belets-
kaya, I.P., Russ. J. Org. Chem., 2010, vol. 46, p. 64.
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 49 No. 1 2013